Literature DB >> 22858444

Is there any relationship between expressions of minor blood group antigens with HTLV-I infection?

Mohammad Hadi Sadeghian1, Mohammad Reza Keramati, Hossein Ayatollahi, Atefeh Shirinzadeh Feizabadi, Farahnaz Tehranaian, Hossein Shakibyee.   

Abstract

BACKGROUND: The frequency of Human T lymphotropic Virus-1 (HTLV 1) is 2-3% in the general population and 0.7% in blood donors in northeast Iran. It is very important that we recognize the contributing factors in the pathogenesis of this virus. There are many reports that show that susceptibility to some infections is closely linked to the expression of certain blood group antigens. This study was performed to evaluate any association between minor blood group antigens and HTLV-I infection in northeast Iran.
METHODS: In this case and control study major and minor blood group antigens were typed by commercial antibodies in 100 HTLV-I infected individuals and 332 healthy blood donors in Mashhad, Iran, from 2009-2010. Blood group antigens were determined by tube method less than 24h after blood collection. Finally, the results of HTLV-I positive subjects and control groups were compared by using SPSS software.
RESULTS: The prevalence of Le(a), Le(b), P1, Fy(a), Fy(b), M, N, Jka, Jkb, K and k antigens in case group were 39.0%, 56.0%, 72.0%, 67.0%, 52.0%, 90.0%, 57.0%, 79.0%, 71.0%, 10.0%, 96.0%, respectively and the frequency of these blood group antigens in control group were 38.8%, 55.8%, 66.2%, 72.0%, 58.7%, 87.0%, 56.7%, 79.8%, 63.0%, 10.6%, 97.0%, respectively. We did not find any significant differences between the case and control group for frequency of minor blood group antigens.
CONCLUSION: Our study showed minor blood group antigens are not associated with an increased risk of HTLT-1 infection in northeast Iran.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22858444     DOI: 10.1016/j.transci.2012.06.012

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  5 in total

1.  JAK2 V617F Mutation in Adult T Cell Leukemia-Lymphoma.

Authors:  Hossein Ayatollahi; Mohammad Hadi Sadeghian; Mohammad Reza Keramati; Ehsan Ghayoor Karimiani; Amir Hossein Jafarian; Abbas Shirdel; Hossein Rahimi; Mohammad Esmaeel Zangane-Far; Arezoo Shajiei; Maryam Sheikhi
Journal:  Indian J Hematol Blood Transfus       Date:  2015-12-17       Impact factor: 0.900

2.  Human T-lymphotropic Virus Type I (HTLV-I) Proviral Load and Clinical Features in Iranian HAM/TSP Patients: Comparison of HTLV-I Proviral Load in HAM/TSP Patients.

Authors:  Rosita Vakili; Faezeh Sabet; Sanaz Aahmadi; Reza Boostani; Houshang Rafatpanah; Ali Shamsian; S A Rahim Rezaee
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

3.  Assessment of HTLV-I proviral load, HIV viral load and CD4 T cell count in infected subjects; with an emphasis on viral replication in co-infection.

Authors:  Hossein Rahimi; Seyyed Abdolrahim Rezaee; Narges Valizade; Rosita Vakili; Houshang Rafatpanah
Journal:  Iran J Basic Med Sci       Date:  2014-01       Impact factor: 2.699

4.  Comparison of HTLV-I Proviral Load in Adult T Cell Leukemia/Lymphoma (ATL), HTLV-I-Associated Myelopathy (HAM-TSP) and Healthy Carriers.

Authors:  Mohammad Mehdi Akbarin; Hossein Rahimi; Tahereh Hassannia; Ghazaleh Shoja Razavi; Faezeh Sabet; Abbas Shirdel
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

Review 5.  Human T Lymphotropic Virus Type I (HTLV-I) Oncogenesis: Molecular Aspects of Virus and Host Interactions in Pathogenesis of Adult T cell Leukemia/Lymphoma (ATL).

Authors:  Sanaz Ahmadi Ghezeldasht; Abbas Shirdel; Mohammad Ali Assarehzadegan; Tahereh Hassannia; Hosian Rahimi; Rahele Miri; S A Rahim Rezaee
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.